Introduction
Transforming growth factor-fJs (TGF-fJs) are multi functional peptide factors, which have been implicated in many functions in nearly all cell types. They belong to a larger super family of structurally similar growth modulators which are found in organisms ranging from nematodes to humans (Kingsley 1994) , TGF-fJs are a subset of 5 isoforms and are homodimers of 25 kDa . They are highly stable molecules and are expressed by almost all cell types in very small quantities (Roberts et at 1988) . The original purification and characterization of TGF-fJ was reported from human placenta (Frolick et at 1983) , human platelets (Assoian et alI983), bovine kidney (Roberts et alI983) , viral transformed cells (Anzano et al 1985) , chemically transformed cells (Moses et al 1981) and from an amphibian cell line (XTC, Roberts et at 1990) . All five isoforms have high homology; the level of similarity in protein sequence identity between isoforms range from 64-82% (Kondaiah et alI990) . TGF-fJs have been shown to play important roles in embryogenesis, inflammation, cellular differentiation and metastasis (Roberts et al1988; Millan et al 1991; Samuel et al 1992) . Out of the 5 isoforms, TGF-ps 1-3 have been identified in mainmals; many of their physiological and clinical roles were established by using these isoforms. TGF-p2, -P3, and -p4 have been. identified in birds, TGF-p2 and -ps in amphibians ) and recently, TGFp2 was reported in fish (Sumathy et al 1997) .
TGF-ps are secreted from all cells in a biologically inactive form called latent TGF-p . Where, the proteolytically cleaved precursor dimers are held together by non covalent interactions. In vitro activation can be brought about by changes in pH or temperature (Brown et al 1990) and in vivo by proteases like plasmin and cathepsin D (Lyons et al 1990) .
The functional significance of mammalian TGF-p isoforms was elucidated by studying TGF-p knockout mice. TGF-p1 knockout mice show a severe inflammatory response (Diebold et al 1995) whereas TGF-p2 and TGF-p3 knockout mice show developmental defects (Sanford et al 1997) and a cleft palate phenotype (Kaartinen et al 1995; Proetzel et al 1995) respectively. Thus TGF-ps play an important role in irnmunomodulation and development. The major potential clinical applications of either TGF-p or antagonists of TGF-p include wound healing, repair of the myocardial infracted heart, bone remodeling and immune suppression . In view of the potential in vivo clinical application of TGF-fJs, recombinant expression of TGF-fJ isoforms has been attempted by several groups in the past (Gentry et al 1987; Bourdrel et al 1993; Graycar et al 1989; Madisen et al 1989) . However, due to the structural complexity of TGF-fJs, only mammalian expression systems resulted in successful expression of TGF-fJ isoforms that mimic natural TGF-fJs. In the above studies, TGF-fJs were expressed in combination with various promoters in mammalian expression systems and reasonable levels of expression were possible only after using methotrexate for amplification of the constructs in the cells. Here, we report recombinant expression of TGF-fJ isoforms in CHO cells without the need for methotrexate amplification. Expression levels are sufficient for further purification to yield small amounts of TGF-fJ for both basic research and applied use.
enzymes (depicted on the primer sequences in table 1) and subcloned into the expression vectors. The cytomegalovirus (CMV) promoter was used to drive expression of TGF-fJ1 and TGF-fJ2 using pRC/CMV (TGF-fJ1) and pCDNA3 (WF-fJ2) vectors (Invitrogen, USA). These vectors have a neomycin resistance gene under the control of the SV40 promoter, which facilitates selection of recombinant clones using G418. After ligation, the recombinants were identified by colony hybridization followed by mini preparations of the plasmids and were confirmed by sequence analysis. Large scale plasmid DNAs from the positive clones were prepared for transfection using Qiagen plasmid isolation columns (Qiagen GmBH, Germany).
Cell cultures
All cell culture reagents were from Life Technologies, USA. The disposable plasticware to grow cells was from Greiner GmbH and Nunc Inc., Germany and from Tarson, Calcutta. Chinese hamster ovary (CHD) cells were grown in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). Penicillin and streptomycin were used at concentrations of 100 units/ml and 100 ~g/rnl, respectively. DMEM-Ham's Fl2 (1 : 1) medium with out serum was used to collect the condition medium from the CHD cell transfectants. G418 was used for the selection of neomycin resistant clones.
Materials and methods
2.
Construction of TGF-fJ expression vector
The TGF-P isofonns were amplified by polymerase chain reaction (PCR) using specific oligonucleotide primers designed to generate specific restriction sites compatible with the expression vectors. Oligonucleotide primers used to amplify TGF-pl and TGF-P2 coding regions are shown in table I. The PCR amplifications were perfonned using cDNA obtained from a human breast carcinoma cell line, MCF7. cDNA equivalent to 1 J.lg of total RNA was used as template in a standard PCR reaction of 35 cycles with 1 min denaturing at 95°C followed by annealing for I min at 58°C and extension at 72°C for 3 min. Amplified products of 1.19 kb and 1.25 kb representing TGF-pl and -/:12 coding regions were obtained (data not shown). The products were digested with the respective
Transfection of expression constructs into mammalian cells and selection of hyperexpression clones
The plasmid DNA was introduced into CHO cells by calcium phosphate mediated transfection (Gorman et at 1982) . This cell line was chosen based on its low Derynck et al (1985) and TGF-{J2 sequences were from de Martin et al (1987) . The translational start codon "A TG" and the stop codon "TCA" (complimentary), are represented in bold. The restriction enzyme cleavage si.es flanking the sequences are underlined.
endogenous expression of TGF-{Js and the ability of the cells to stay alive in serum free cultures proves that facilitate isolation of more secreted proteins from the media. Transfections were performed using 2 j.tg and 5 j.tg of super-coiled plasmid DNA. After 48 h post-transfection, cells were placed in selection media containing 1-2 j.tg/ml G418. After the elimination of cells which do not contain the expression plasmid, G418 resistant clones were individually isolated using sterile glass clonal rings (Bellco Inc., USA) and were transferred to 24 well culture plates.
for 2 h. The cells were washed, fixed and solubilized and radioactivity measured in a scintillation counter. TGF-p was e'stimated by using a standard curve prepared simultaneously by using the same procedure.
2.6 RNA extraction and hybridization
Total RNA was extracted from CHO cells using one-step purification by guanidium isothiocyanate (Chomczynski and Sacchi 1987) and the RNA concentration was determined by measuring absorbance at 260 nm. Ten ~g of total RNA was analysed on a 1 % agarose-formaldehyde gel and blotted onto a Hybond-N nylon membrane (Amersham, UK). Prehybridization and hybridization were carried out at 65°C in a buffer containing 1 % bovine serum albumin, 7% SDS, 1 roM EDT A and 0.5 M disodium hydrogen phosphate (pH 7.0) (Church and Gilbert 1984) . The probes were labelled with r2p]dCTP (NEN Life Sci, USA) by the random primed method using the megaprime labelling kit (Amersham, UK). Hybridizations were carried out for about 16 h and the blots were washed with 2 x SSC at room temperature for 30 min and for another 30 min with 0.2 x SSC at 65°C and exposed to Hyperfilm (Amersham, UK) at -70°C.
2.4 Collection of conditioned media and TGF-fJ assays 2.7 Western blot analysis of TGF-fJl
The clones were expanded and were plated individually for collection of conditioned media and were also frozen for subsequent use. The cells were seeded in 24 well clusters for the isolation of conditioned media and were allowed to grow for two days in DMEM supplemented with 10% fetal bovine serum and antibiotics. After the cells reached confluence, they were washed with serum free DMEM thrice for 1-2 h each. Finally, 0.5 ml of serum free medium was added to each clone and the medium was collected after 20-24 h. Media wer~cen-trifuged at 10,000 g to remove debris and supernatants were frozen at -20°C until further processing. An aliquot of the conditioned medium from each clone was activated by heating at 80°C for 15 min and kept on ice prior to assay. This treatment releases the bioactive TGF-p from the latent complex. Serial dilutions of conditioned media containing activated TGF-{:J were assayed by CCL64 (obtained from American Type Culture Collection, Maryland, USA) cell growth inhibition assay to estimate biological activity in the samples.
Conditioned medium from TGF-pl transfected CHO cells \Vas subjected to Western blot analysis. Samples were electrophoresed on 15% SDS-PAGE, transferred to a PVDF (Amersham, UK) membrane and blocked with NET buffer (150 mM NaCI, 0.005 mM EDT A at pH 8.0, 50mM Tri$ HCI, pH 7.5, 2% BSA, 0.05% Triton X-100). The blot was incubated overnight at 4QC with 10 I.1g/ml of primary antibody, which is a polyclonal antibody rai$ed against amino acid 1-30 of the mature TGF-pl protein . The blot was washed extensive.ly in 1 x PBS and 0..1 % Tween 20 and subsequently incubated f()r 1 h at room temperature with goat anti,rabbit HRP conjugate according to manufacturer's in$tructions (Amersham Life Science). Immunodetection of TGP-pl protein was by chemilumini$cence (ECL sY$tem, Amersham, UK).
CCL64 mink lung epithelial cell growth inhibition assay
This is a bioassay designed to detect TGF-fJ in the samples and is highly sensitive in the range of 25-200 pg/ml of the TGF-fJs (Danielpour et at 1989) . It is based on an important property of TGF-fJ, namely the growth inhibition of epithelial cells. Although this assay does not distinguish between the isoforms, one can estimate 1he level of each isoform by using isoform specific neutralizing antibodies. Briefly about 2.5 x 105 cells were seeded in 24 well plates in assay buffer (DMEM with 0.2% FBS). After the cells attached (after about 2 h), the samples containing TGF-fJ with and without antibodies (if specific isoform is assayed) were added and the cells were allowed to grow for 18-22 h. To monitor growth inhibition, 0.5 ~Ci of [3H]thymidine (sp. act. of "10-90 Ci/mM, NEN Life Sci. Products, USA) was added to each well and DNA synthesis permitted
Results
The clones were isolated after transfection and selection for about two weeks in 1 ~g/ml of G4I8 containing media. A total of 48 clones transfected with the TGFfJI construct were isolated and the conditioned medium from each clone was assayed by using a TGF-fJI specific immunoassay (Quantakine system, Rand D Systems, USA). Initially, pairs of TGF-fJI clones were tested for their ability to synthesize the protein (data not shown).
3.5 kb appears to be an mRNA transcribed by the CMV promoter that includes both the TGF-{JI coding region and the coding region of the downstream neomycin resistance gene. The size corresponds well with the fused mRNA that utilizes the polyadenylation site of the neomycin resistance gene. RNA from vector transfected CHO cells or TGF-{J1-8 and 9 clones (figure 1, lanes 1, 2 and 3) did not show any detectable TGF-{JI transcript, again correlating well with the low levels of the protein expressed by these clones. To further confirm the ide:ntity of recombinant bioactive TGF-{JI in the conditioned medium, Western blot analysis was performed (figure 2). A polyclonal antibody raised against amino acids 1-30 of the mature TGF-{JI protein was used. As is evident from figure 2, a single protein band of size 12.5 kDa was identified in the conditioned medium of clone TGF-{J1-24. Recombinant human TGF-{JI protein (a gift from Dr Anita Roberts) was used as a standard and an identical band obtained in the clone confirmed that a processed mature TGF-{JI protein was present in the conditioned medium. The claim, that the secreted factor from clone 24 is TGF-{JI is based on other findings as well; for exampl,e, the observation that clones transfected with the control,vector do not express recombinant RNA (figure 1).
As TGF-{J1-24 clone expresses considerable amounts of the protein, this clone will be used for the large-scale purification of the recombinant, fully processed protein. Purification will be achieved using gel filtration, ion exchange chromatography and HPLC.
The basal level of TGF-pl secreted by CHO cells transfected with vector alone (control) was approximately 3.5 ng/ml; prelinl.inary results indicate that some of the expressing clones result in greater than 40 ng of protein being secreted per ml of conditioned medium. Based on the preliminary results from the Quantakine assay, conditioned media from 4 individual clones were tested by CCL64 assay (table 2). As shown in table 2, two individual TGF-pl clones, TGF-f31-2 and TGF-pl-24 expressed 120 and 350 ng/ml respectively of TGF-pl protein in the conditioned medium. Conditioned media collected from 69 TGF-p2 transfected clones were tested for TGF-p2 expression levels (data not shown) and 12 clones expressed greater than 80 ng/ml TGF-p2 (table 2) . One TGF-p2 clones (clone 49), which showed 120ng/ ml/day expression, was selected for further characterization. In order to assess the sustained production of the recombination protein from these clones, the TGFpl-24 and TGF-p2-49 clones were cultured for 3 days in serum free medium and the TGF-p secreted in the conditioned medium was estimated to be approximately 970 ng/ml for TGF-pl-24 and 244 ng/ml for TGF-p2-49 clone (table 3) . This higher level of expression in 3 day collection correlated well with the production in one day by the respective clones.
As the amount of TGF-pl produced by the TGF-pl-2 and TGF-pl-24 clones was considerable, they were further characterized by RNA analysis. Northern blot analysis revealed two specific transcripts of 1.5 kb and 3.5 kb (figure 1). There was a high ..level of mRNA that was specific to the construct that was transfected (1.5 kb message) in cloneTGF-p1':'24 and' 'th'e'mRNA corite,nt was correlated with the level of protein expression from these clones. The higher molecular weight mRNA of Discussion Recombinant expression of peptide factors has become a powerful tool for a variety of applications ranging from basic Tesearch to human therapy. Several expression systems for the large-scale produetion of proteins have been developed over the last two decades, with the choice of the system depending on the nature and potential application of the specific protein. For example, if the protein does not have any complex structural constrains, one can use a simple and inexpensive prokaryotic expression system using Escherichia coli as the host. The disadvantage in using a prokaryotic system for the expression of mammalian proteins is improper folding and lack of glycosylation in these systems. Some features of eukaryotic expression could be achieved in yeast and expression systems, but expression levels were extremely low (in the range of 10~20 ng/ml of conditioned medium) and hence the method was not viable (Gleizes et al 1996) . TGF-{3 has been purified from the human platelets, which are a major natural source of the protein (Assoian et al 1983) . However, the yield obtained was much less when compared to that obtained using the mammalian expression system. TGF-{31 has been expressed in CHO cells using vectors with the SV40 early promoter after gene amplification using methotrexate (Gentry et al 1987) . TGF-{32 expression has been achieved in the mammalian expression system using the CHO cell line expressing the hybrid TGF-{3-1 (NHJ/beta-2 (COOH) construct (Madisen et al 1989) . Investigators have also reported the recombinant expression and purification of TGF-{33 in a mammalian system (Gray car et al 1989) . However, all the above systems have used expression strategies using methotrexate and dihydro folate reductase deficient CHO (dhfr-CHO) cells for isolation and further purification of TGF-{3s. One disadvantage in using dhfr amplification is the requirement of using mutant CHO cells deficient in dhfr enzyme. In addition, the large amount of methotrexate required for amplification of the plasmids in the cells makes it prohibitively expensive. Our results demonstrate the feasibility of expressing TGF-{3s without the need for dhfr-CHO cells and methotrexate amplification. In addition, the secreted pro-t~ins were found to be biologically active. The higher levels of TGF-{31 expression obtained by us without baculovirus expression systems. The yeast Saccharomyc es cervisiae and more recently, Pichia pastoris have been used to express and purify recombinant human proteins. The above systems have the combined advantage of producing large quantities and preserving the bioactivity of the respective protein, but a probl~m encountered while using the yeast expression systems is over mannosylatio n of the protein. However, there are some proteins with high structural complexity and to produce them in a bioactive form, one has to depend on mammalian expression systems; these can be used to get a fully processed, glycosylated and biologically active protein. Several growth factors, hormones, r~ceptors, and transcription factors have been successfully expressed using mammalian expression systems. Hence the mammalian expression systems offer a number of advantages over the above mentioned systems.
Several investigators including ourselves have attempted expression of TGF-p proteins in E. coli. The approaches were either to express full-length TGF-{J precursor or only the maturel12 amino acid single chain. The full length precursor did not yield any noticeable expression, possibly due,tp proteolytic degradation of the protein or inappropriate codon psage. When the mature region of the cDNA 'was used, although protein expression was feasible in E. coli, the protein could not be folded and dimerized. Recombinant expression of TGF-{JI was also ",.. . attempted In Sf9 (insect) cells using a baculovirus expression syst~m. A functional, mature TGF-{JI was present in the conditioned medium, as in mammalian amplification of the plasmid appears to be due to the combined use of a powerful eukaryotic promoter, the cytomegalovirus early promoter, and altering the culture conditions (high density culturing of the cells in smaller quantities of the serum free medium). This allows the concentration of the secreted proteins. TGF-fJ was found to be a very stable protein, not easily degraded, the secreted proteins might have retained activity over time. It is possible to improve the yields by culturing the cells for longer perio.ds; CHO cells can be maintained in serum free conditions for as long as 5 days with out much loss of cells (P Kondaiah, personal observation). Although our expression system yields (2-3-fold) lower levels than attainable by amplified expression, one can improve by manipulating the culture conditions. Moreover, the method can be used for the recombinant expression of any other bio-active protein which needs complex post translational processing of modifications.
